(S)-WAY 100135, a 5-HT 1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine

By Carli M.   Luschi R.   Samanin R.  

European Journal of Pharmacology, Vol. 283, Iss. 1, 1995-09 ,pp. : 133-139

Elsevier

Access to resources Recommend Favorite

In vivo intrinsic efficacy of the 5-HT 1A receptor antagonists NAD-299, WAY-100,635 and (S)-(-)-UH-301 at rat brain monoamine receptors

By Ahlenius S.   Henriksson I.   Magnusson O.   Salmi P.  

European Neuropsychopharmacology, Vol. 9, Iss. 1, 1999-01 ,pp. : 15-19

Elsevier

Access to resources Recommend Favorite

Anxiolytic-like effects of the selective 5-HT 1A receptor antagonist WAY 100635 in non-human primates

By Barros M.   Mello E.L.   Maior R.S.   Muller C.P.   de Souza Silva M.A.   Carey R.J.   Huston J.P.   Tomaz C.  

European Journal of Pharmacology, Vol. 482, Iss. 1, 2003-12 ,pp. : 197-203

Elsevier

Access to resources Recommend Favorite

Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT 1A receptor antagonist, on 8-OH-DPAT responses

By Trillat A.-C.   Malagie I.   Mathe-Allainmat M.   Anmela M.-C.   Jacquot C.   Langlois M.   Gardier A.M.  

European Journal of Pharmacology, Vol. 347, Iss. 1, 1998-04 ,pp. : 41-49

Elsevier

Access to resources Recommend Favorite

Synergistic actions of the 5-HT 1A receptor antagonist WAY-100635 and citalopram on male rat ejaculatory behavior

By Ahlenius S.   Larsson K.  

European Journal of Pharmacology, Vol. 379, Iss. 1, 1999-08 ,pp. : 1-6

Elsevier

Access to resources Recommend Favorite